Why the study?
Does the presence of beta-blockers alter the effects of intracoronary contrast media on myocardial contractility and conduction in rabbit hearts?
Does the presence of beta-blockers alter the effects of intracoronary contrast media on myocardial contractility and conduction in rabbit hearts?
Answers are grounded in this paper and cite their sources.
The adverse interaction between beta-blockers and intracoronary contrast media on myocardial function is minimized by using nonionic contrast media and beta-blockers without membrane stabilizing activity.
The effects of ionic, meglumine sodium diatrizoate (Urografin 76) and nonionic, iohexol contrast media were examined in the absence and presence of propranolol, a beta-blocker having nonspecific membrane stabilizing action and atenolol, a beta-blocker lacking nonspecific membrane stabilizing action on Langendorff-perfused rabbit hearts. Contrast medium, 0.7 ml, was injected into the aortic root in the absence and presence of 10(-7) and 10(-5) M beta-blocker to observe the changes in resting tension, force of contraction, rate of contraction, heart rate and PR interval. Beta-blockers and contrast media interact in affecting myocardial contractility, heart rate and atrioventricular conduction. The interaction is milder when the beta-blocker lacks membrane stabilizing activity and the contrast medium is nonionic.
No takes yet. Share an insight, caveat, or question.
Salbaş et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: